| Basic Medical Information |
| Common Brand Name |
| Inderal |
Altace |
| Drug Class |
| Anti-adrenergics |
Ace Inhibitors |
| Legal Status |
| Prescription Only (s4) (au), Pom (uk), Rx-only (us) |
Pom (uk), Rx-only (us) |
| Possible Side Effects |
| Dizziness, Lightheadedness, Nausea, Vomiting, Stomach Pain, Vision Changes, Insomnia, Vivid Dreams, Nightmares |
Low Blood Sugar, Dry Cough, Dizziness, Tiredness, Mouth Dryness, Nausea, Vomiting, Diarrhea, Fainting, Change In Amount Of Urine, Yellowing Of Eyes Or Skin, Dark Urine, Abdominal Pain, Neutropenia, Impotence |
| Precautions & Contraindications |
| Asthma, Chronic Obstructive Pulmonary Disease, Bradycardia, Sick Sinus Syndrome, Atrioventricular Block, Shock, Severe Hypotension |
Angina, Atherosclerosis, Mitral Insufficiency, Renovascular Hypertension, Diabetic Or Nondiabetic Nephropathy, Erythrocytosis |
| Excretion |
| Renal |
Renal, Fecal |
|
| Dosage, Usage and Forms |
| Route of Administration |
| Oral, Iv |
Oral |
| Dosage |
| 40 Mg
Twice/day |
2.5 Mg |
| Maximum daily dose |
| 200 mg |
20 mg |
| Forms |
| Capsule, Suspension, Iv, Tablet |
Capsule |
| Tablet Formulations |
| 10 Mg, 20 Mg, 40 Mg, 60 Mg, 80 Mg |
|
| Capsule Formulations |
| 60 Mg, 80 Mg, 120 Mg, 160 Mg |
1.25 Mg, 2.5 Mg, 5 Mg, 10 Mg |
| IV Solution Formulations |
| 1 Mg/ml |
|
| Oral Suspension |
| 4 Mg/ml, 8 Mg/ml |
|
| Chemical Data |
| Molecular mass (g/mol) |
| 259.34 g/mol |
416.51 g/mol |
| Half Life (hours) |
| 5 |
4 |
| Chemicals |
| Carbon, Hydrogen, Nitrogen, Oxygen |
Carbon, Hydrogen, Nitrogen, Oxygen |
| Formula |
| C16h21no2 |
C23h32n2o5 |
| Melting Point (C) |
| 164 C |
109 C |
| Phase (solid/liquid) |
| Solid, Liquid |
Solid |